Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois. more
Time Frame | MAIA | Sector | S&P500 |
---|---|---|---|
1-Week Return | -4.93% | 0.49% | -0.42% |
1-Month Return | -1.85% | -3.1% | -2.2% |
3-Month Return | -19.7% | -8.59% | 2.38% |
6-Month Return | -45.08% | -4.57% | 5.1% |
1-Year Return | 47.74% | -0.94% | 23.79% |
3-Year Return | -52.47% | 2.88% | 26.66% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Cost of Revenue | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Profit | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Gross Margin | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Operating Expenses | 6.92M | 6.98M | 7.74M | 15.86M | 20.18M | [{"date":"2019-12-31","value":34.29,"profit":true},{"date":"2020-12-31","value":34.56,"profit":true},{"date":"2021-12-31","value":38.36,"profit":true},{"date":"2022-12-31","value":78.6,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (6.92M) | (6.98M) | (7.79M) | (16.18M) | (20.18M) | [{"date":"2019-12-31","value":-692136000,"profit":false},{"date":"2020-12-31","value":-697560100,"profit":false},{"date":"2021-12-31","value":-778662700,"profit":false},{"date":"2022-12-31","value":-1617620100,"profit":false},{"date":"2023-12-31","value":-2018238100,"profit":false}] |
Total Non-Operating Income/Expense | - | (15.19K) | (5.62M) | 401.82K | 437.10K | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-3.48,"profit":false},{"date":"2021-12-31","value":-1285.08,"profit":false},{"date":"2022-12-31","value":91.93,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (6.92M) | (6.96M) | (12.58M) | (15.77M) | (19.77M) | [{"date":"2019-12-31","value":-692111400,"profit":false},{"date":"2020-12-31","value":-695924800,"profit":false},{"date":"2021-12-31","value":-1257821100,"profit":false},{"date":"2022-12-31","value":-1576927900,"profit":false},{"date":"2023-12-31","value":-1977290500,"profit":false}] |
Income Taxes | (435.25K) | (291.04K) | 707.53K | 36.69K | (176.72K) | [{"date":"2019-12-31","value":-61.52,"profit":false},{"date":"2020-12-31","value":-41.13,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":5.19,"profit":true},{"date":"2023-12-31","value":-24.98,"profit":false}] |
Income After Taxes | - | (6.67M) | (13.29M) | (15.81M) | (19.60M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-666820700,"profit":false},{"date":"2021-12-31","value":-1328574100,"profit":false},{"date":"2022-12-31","value":-1580596800,"profit":false},{"date":"2023-12-31","value":-1959618600,"profit":false}] |
Income From Continuous Operations | - | (6.96M) | (12.58M) | (15.77M) | (19.77M) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-695924800,"profit":false},{"date":"2021-12-31","value":-1257821100,"profit":false},{"date":"2022-12-31","value":-1576927900,"profit":false},{"date":"2023-12-31","value":-1977290500,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (6.49M) | (6.67M) | (13.29M) | (15.81M) | (19.77M) | [{"date":"2019-12-31","value":-649278200,"profit":false},{"date":"2020-12-31","value":-666820700,"profit":false},{"date":"2021-12-31","value":-1328574100,"profit":false},{"date":"2022-12-31","value":-1580596800,"profit":false},{"date":"2023-12-31","value":-1977290500,"profit":false}] |
EPS (Diluted) | - | - | - | (2.01) | (1.49) | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-201,"profit":false},{"date":"2023-12-31","value":-149,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
MAIA | |
---|---|
Cash Ratio | 2.41 |
Current Ratio | 2.56 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
MAIA | |
---|---|
ROA (LTM) | -107.11% |
ROE (LTM) | -559.56% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
MAIA | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.82 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.18 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
MAIA | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 34.26 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
MAIA Biotechnology Inc. (MAIA) share price today is $2.12
Yes, Indians can buy shares of MAIA Biotechnology Inc. (MAIA) on Vested. To buy MAIA Biotechnology Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MAIA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of MAIA Biotechnology Inc. (MAIA) via the Vested app. You can start investing in MAIA Biotechnology Inc. (MAIA) with a minimum investment of $1.
You can invest in shares of MAIA Biotechnology Inc. (MAIA) via Vested in three simple steps:
The 52-week high price of MAIA Biotechnology Inc. (MAIA) is $5.99. The 52-week low price of MAIA Biotechnology Inc. (MAIA) is $0.99.
The price-to-earnings (P/E) ratio of MAIA Biotechnology Inc. (MAIA) is
The price-to-book (P/B) ratio of MAIA Biotechnology Inc. (MAIA) is 34.26
The dividend yield of MAIA Biotechnology Inc. (MAIA) is 0.00%
The market capitalization of MAIA Biotechnology Inc. (MAIA) is $55.45M
The stock symbol (or ticker) of MAIA Biotechnology Inc. is MAIA